Meeting
2021 ASCO Annual Meeting
Survival (OS) and progression-free survival (PFS) results after induction chemotherapy (IC) followed by de-escalated chemoradiotherapy (RDCRT) for locally advanced (LA) HPV positive oropharynx cancer (HPVOPC.
Authors
Marshall R. Posner
Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
Marshall R. Posner , Krzysztof Misiukiewicz , Brett A. Miles , Sonam Sharma , Vishal Gupta , Eric Michael Genden , John Botzler , Isaiah Selkridge , Erin Moshier , Vruti Virani , Richard Lorne Bakst
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Clinical Trial Registration Number
NCT02945631, NCT01706939
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 6058)
DOI
10.1200/JCO.2021.39.15_suppl.6058
Abstract #
6058
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The Quarterback trials: A phase 2 series of sequential studies of induction chemotherapy followed by reduced dose chemoradiation for human papillomavirus positive oropharynx cancer.
First Author: Marshall R. Posner
Poster
2011 ASCO Annual Meeting
Chemoselection with induction chemotherapy followed by chemoradiation or surgery versus chemoradiation for patients (pts) with locally advanced squamous cell carcinoma of the oropharynx (LASCCOP).
First Author: I. Y. Dobrosotskaya
Poster
2017 ASCO Annual Meeting
Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients.
First Author: Hope Rainey
Poster
2015 ASCO Annual Meeting
Response-adapted volume de-escalation (RAVD) of radiotherapy (RT) using induction chemotherapy (IC) in locally advanced head and neck squamous cell cancer (LA-HNSCC).
First Author: Victoria Meucci Villaflor